跳至主要内容
临床试验/NCT03620591
NCT03620591已完成不适用

Intraoperative Use of Lidocaine and Postoperative Analgesia After Laparoscopic Cholecystectomy

Larissa University Hospital1 个研究点 分布在 1 个国家目标入组 98 人开始时间: 2018年7月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
98
试验地点
1
主要终点
Postoperative opioid consumption

研究概览

简要总结

The purpose of this study is to evaluate how effective is the intraoperative use of lidocaine to attenuate postoperative pain and opioids consumption after laparoscopic cholecystectomy

详细描述

Acute postoperative pain may predict the development of chronic pain.Recently, the analgesic effect of lidocaine, as a part of a multimodal analgesia, has been evaluated in many studies. They have shown that lidocaine may have a role in the postoperative pain management, as an adjunct.

Acute postoperative pain after laparoscopic cholecystectomy is complex in nature. Postoperative pain is the main complaint and the primary reason for delay discharge after laparoscopic cholecystectomy.The study includes patients undergoing laparoscopic cholecystectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA physical status I-II
  • Age ≥ 18 years old

排除标准

  • Allergy in local anesthetics
  • History of liver, kidney or heart failure
  • Existence of chronic pain history or daily analgesics
  • Psychiatric disorders
  • Inability to understand pain assessment

研究组 & 干预措施

Lidocaine

Active Comparator

Intraoperative administration of lidocaine to patients undergo laparoscopic cholecystectomy.

Prior induction to anesthesia, lidocaine bolus 1.5 mg / kg will be administered to the lidocaine group and then patients will be connected to a continuous 2 mg / kg / h administration of lidocaine until the end of the procedure.

干预措施: Lidocaine (Drug)

Placebo

Placebo Comparator

Intraoperative administration of normal saline to patients undergo laparoscopic cholecystectomy.

干预措施: Placebo (Drug)

结局指标

主要结局

Postoperative opioid consumption

时间窗: 24 hours after the procedure

The total dose of tramadol is calculated as mg and administered intravenously.

次要结局

  • Change from Baseline Heart Rate(Intraoperative)
  • Incidence of shoulder pain(24 hours)
  • Change from baseline Mean Blood Pressure(Intraoperative)
  • Incidence of sedation and respiratory depression(24 hours)
  • Incidence of headache and dizziness(24 hours)
  • Change in depth of anesthesia(Intraoperative)
  • Incidence of Nausea and Vomiting(24 hours)
  • Postoperative pain(24 hrs after the procedure)
  • Side effect related to administration of lidocaine(24 hours)

研究者

发起方
Larissa University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ioannis Baloyiannis

Assistant Professor of Surgery

Larissa University Hospital

研究点 (1)

Loading locations...

相似试验